Cargando…
TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype
The heterogeneous nature of colorectal cancer (CRC) complicates prognosis and is suggested to be a determining factor in the efficacy of adjuvant therapy for individual patients. Based on gene expression profiling, CRC is currently classified into four consensus molecular subtypes (CMSs), characteri...
Autores principales: | Fessler, Evelyn, Drost, Jarno, van Hooff, Sander R, Linnekamp, Janneke F, Wang, Xin, Jansen, Marnix, De Sousa E Melo, Felipe, Prasetyanti, Pramudita R, IJspeert, Joep EG, Franitza, Marek, Nürnberg, Peter, van Noesel, Carel JM, Dekker, Evelien, Vermeulen, Louis, Clevers, Hans, Medema, Jan Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931289/ https://www.ncbi.nlm.nih.gov/pubmed/27221051 http://dx.doi.org/10.15252/emmm.201606184 |
Ejemplares similares
-
Polyps and Colorectal Cancer in Serrated Polyposis Syndrome: Contribution of the Classical Adenoma-Carcinoma and Serrated Neoplasia Pathways
por: van Toledo, David E. F. W. M., et al.
Publicado: (2023) -
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype
por: Fessler, E, et al.
Publicado: (2016) -
The earliest events in
BRAF
‐mutant colorectal cancer: exome sequencing of sessile serrated lesions with a tiny focus dysplasia or cancer reveals recurring mutations in two distinct progression pathways
por: Bleijenberg, Arne GC, et al.
Publicado: (2022) -
Capturing colorectal cancer inter‐tumor heterogeneity in patient‐derived xenograft (PDX) models
por: Prasetyanti, Pramudita R., et al.
Publicado: (2018) -
Intra-tumor heterogeneity from a cancer stem cell perspective
por: Prasetyanti, Pramudita R., et al.
Publicado: (2017)